ClinicalTrials.gov
public full text
Public Domain
Effect of Erythropoietin on Neurodevelopmental Outcomes in Very Preterm Infants With Intraventricular Hemorrhage
Erythropoietin (EPO) has been shown to be neurotrophic and neuroprotective in several animal models and some clinical studies. Our hypothesis is that EPO could improve long-term neurological outcomes in very preterm infants with intraventricular hemorrhage (IVH). The aim of this study is to evaluate the long-term neuroprotective effect of repeated low-dose EPO (500 U/kg) in very preterm infants with IVH.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Preterm Erythropoietin Neuroprotection Trial (PENUT Trial)#143694
- The Correlation Between Red Cell Transfusion and Complications of Prematurity#1172540
- Finding Solutions to Thrive After Birth Asphyxia in Africa#1140592
- Protocol for a real-world-data enabled, 2-randomisation, adaptive trial to determine the clinical efficacy and safety of widely used enteral feeds in preterm babies: The COLLABORATE trial#1067991
- Tranexamic Acid as an Intervention in Placenta Previa#894178
Record · ID 895146
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive